Bell & Brown Wealth Advisors, LLC Amgen Inc Transaction History

Bell & Brown Wealth Advisors, LLC

$256 Million
Q3 2024

A detailed history of Bell & Brown Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bell & Brown Wealth Advisors, LLC holds 9,842 shares of AMGN stock, worth $2.85 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares

9,842

Previous 9,793 0.5%

Holding current value

$2.85 Million

Previous $3.06 Million 3.66%

% of portfolio

1.24%

Previous 1.25%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $15,159 - $16,531	49 Added 0.5%	9,842 $3.17 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $59,381 - $72,164	-226 Reduced 2.26%	9,793 $3.06 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $187,133 - $225,893	696 Added 7.47%	10,019 $2.85 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $210,952 - $237,979	825 Added 9.71%	9,323 $2.69 Million
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $11,570 - $13,681	-54 Reduced 0.63%	8,498 $1.89 Million
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $38,384 - $46,784	-170 Reduced 1.95%	8,552 $2.07 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $24,048 - $30,556	-105 Reduced 1.19%	8,722 $2.29 Million
Q3 2022 Oct 26, 2022	SELL	$224.46 - $253.15 $14,140 - $15,948	-63 Reduced 0.71%	8,827 $1.99 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $44,988 - $50,064	-195 Reduced 2.15%	8,890 $2.16 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $36,179 - $40,024	-165 Reduced 1.78%	9,085 $2.2 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $138,420 - $158,409	696 Added 8.14%	9,250 $2.2 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $48,185 - $56,454	-227 Reduced 2.59%	8,554 $1.82 Million
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $27,219 - $30,270	-116 Reduced 1.3%	8,781 $2 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $26,506 - $32,527	-134 Reduced 1.48%	8,897 $2.16 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $46,835 - $62,116	-257 Reduced 2.77%	9,031 $2.16 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $42,572 - $54,720	-225 Reduced 2.37%	9,288 $2.24 Million
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $2,611 - $3,129	15 Added 0.16%	9,513 $1.83 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $35,840 - $42,013	215 Added 2.32%	9,498 $1.75 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $10,852 - $12,232	60 Added 0.65%	9,283 $1.76 Million
Q4 2018 Feb 22, 2019	SELL	$178.4 - $208.25 $2.59 Million - $3.02 Million	-14,492 Reduced 61.11%	9,223 $1.8 Million
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $2.63 Million - $3.06 Million	14,717 Added 163.56%	23,715 $4.62 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $21,308 - $24,022	-115 Reduced 1.26%	8,998 $1.74 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $24,907 - $27,976	150 Added 1.67%	9,113 $1.68 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $33,886 - $39,600	-200 Reduced 2.18%	8,963 $1.53 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.55 Million - $1.73 Million	9,163	9,163 $1.59 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell & Brown Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bell & Brown Wealth Advisors, LLC with notifications on news.

Account

Bell & Brown Wealth Advisors, LLC Amgen Inc Transaction History